Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Takahiko Horiuchi Last modified date:2022.08.05

Professor / Kyushu University Hospital

1. Maeda T, Horiuchi T, Makino N, Chromosomal terminal methylation status is associated with gut microbiotic alterations, Mol. Cell. Biochem., 476, 1, 157-163, 2021.01.
2. Hashimura C, Kiyohara C, Fukushi J-I, Hirose T, Ohsawa I, Tahira T, Horiuchi T, Clinical and genetic features of hereditary angioedema with and without C1-inhibitor (C1-INH) deficiency in Japan., Allergy, 10.1111/all.15034, 76, 11, 3529-3534, 2021.11.
3. Wang Q, Oryoji D, Mitoma H, Kimoto Y, Koyanagi M, Ayano M, Akahoshi M, Arinobu Y, Niiro H, Akashi K, Horiuchi T, Methotrexate enhances apoptosis of transmembrane TNF-expressing cells treated with an anti-TNF agent, Front. Immunol, 10.3389/fimmu.2020.02042, 2020.08.
4. Inokuchi S, Mitoma H, Kawano S, Nakano S, Ayano M, Kimoto Y, Akahoshi M, Arinobu Y, Tsukamoto H, Akashi K, Horiuchi T, Niiro H, Homeostatic milieu induces production of deoxyribonuclease 1-like 3 from myeloid cells, J Immunol, 10.4049/jimmunol.1901304, 204, 8, 2088-2097, 2020.08.
5. Higuchi Y, Niidome T, Miyamoto Y, Komohara Y, Tokunou T, Kubota T, Horiuchi T, Accumulation of gold nano-rods in the failing heart of transgenic mice with the cardiac specific expression of TNF-alpha, Heart Vessels, 34, 3, 538-544, 2019.04.
6. Otsuka Y, Kiyohara C, Kashiwado Y, Sawabe T, Nagano S, Kimoto Y, Ayano M, Mitoma H, Akahoshi M, Arinobu Y, Niiro H, Akashi K, Horiuchi T, Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study., PLoS One, 13, 4, e0196368, 2018.04.
7. Yakushiji H, Hashimura C, Fukuoka K, Kaji A, Miyahara H, Kaname S, Horiuchi T, A missense mutation of the plasminogen gene in hereditary angioedema with normal C1 inhibitor in Japan., Allergy, 73, 11, 2244-2247, 2018.11.
8. Naoyasu Ueda, Takahiko Horiuchi, Clinical and genetic features of patients with TNFRSF1A variants in Japan: Findings of a nationwide survey, Arthritis Rheumatol, 68, 11, 2760-2771, 2016.11.
9. Ayano M, Tsukamoto H, Kohno K, Ueda N, Tanaka A, Mitoma H, Akahoshi M, Arinobu Y, Niiro H, Horiuchi T, Akashi K, Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis., J. Immunol., 195, 3, 892-900, 2015.03.
10. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y, Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in Japan., Cytokine, 65, 1, 88-94, 2014.01.
11. Ueda N, Tsukamoto H, Mitoma H, Ayano M, Horiuchi T, The cytotoxic effects of certolizumab pegol and golimumab mediated by transmembrane tumor necrosis factor α, Inflamm Bowel Dis, 2013.05.
12. Tetsuro Yamamoto, Koichi Akashi, Takahiko Horiuchi, Hereditary angioedema in Japan: Genetic analysis of 13 unrelated cases., Am J Med Sci, 343, 3, 210-214, 2012.03.
13. Hiroshi Tsukamoto, koji nagafuji, Takahiko Horiuchi, koichi akashi, Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells., Rheumatology (Oxford) , 50, 5, 944-952, 2011.05.
14. Kimoto Y, Horiuchi T, Tsukamoto H, Kiyohara C, Mitoma H, Uchino A, Furugo I, Yoshizawa S, Ueda A, Harashima S, Sawabe T, Tahira T, Hayashi K, Yoshizawa S, Shimoda T, Akashi K, Harada M, Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections., Rheumatology (Oxford) , 49 , 7, 1346~1353, 2010.07.
15. Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T, Transmembrane TNF-α: structure, function and interaction with anti-TNF agents., Rheumatology (Oxford), 49, 7, 1215-1228, 2010.07.
16. Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Takahashi M, Oryoji K, Yoshizawa S, Shimoda T, Niiro H, Otsuka T, Tada Y, Nagasawa K, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T, Safety and potential efficacy of tacrolimus for treatment of lupus nephritis with persistent proteinuria, Clin Exp Rheumatol, 28, 1, 6-12, 2010.01.
17. Mitoma H, Horiuchi T, Tsukamoto H, Tamimoto Y, Kimoto Y, Uchino A, To K, Harashima S, Hatta N, Harada M : , Mechanisms for cytotoxic effects of anti-TNF agents on transmembrane TNF-expressing cells: comparison among infliximab, etanercept and adalimumab.
, Arthritis Rheum , 58(5): 1248-1257, 2008
, 2008.05.
18. Horiuchi T, Kiyohara C, Tsukamoto H, Sawabe T, Furugo I, Yoshizawa S, A functional M196R polymorphism of tumor necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis, Ann Rheum Dis, 66: 320-324, 2007.03.
19. Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y., Mutation in DNase I in people with systemic lupus erythematosus, Nature Genetics, 10.1038/91070, 28, 4, 313-314, 28: 313-314, 2001, 2001.08.